INDAYO 0.03 MG — DIN 02398869
ETHINYL ESTRADIOL : 0.03 MG LEVONORGESTREL : 0.15 MG · MYLAN PHARMACEUTICALS ULC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is INDAYO?
INDAYO 0.03 MG contains ETHINYL ESTRADIOL : 0.03 MG LEVONORGESTREL : 0.15 MG. It is listed in the Health Canada Drug Product Database under DIN 02398869, held by MYLAN PHARMACEUTICALS ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 08-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Levonorgestrel And Estrogen cost around the world?
Levonorgestrel And Estrogen is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Brazil publishes a preco fabrica (ex-factory ceiling). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Spain | PVP con IVA (public price) | 26 | 26 | EUR███.██ |
| South Africa | single exit price | 20 | 20 | ZAR███.██ |
| Australia | ex-manufacturer | 16 | 17 | AUD███.██ |
| Brazil | preco fabrica (ex-factory ceiling) | 11 | 14 | BRL███.██ |
| Sweden | AIP (pharmacy purchase price) | 7 | 14 | SEK███.██ |
| Norway | max AUP (pharmacy retail) | 9 | 12 | NOK███.██ |
| Saudi Arabia | public | 4 | 6 | SAR███.██ |
| Morocco | PPV (public price) | 3 | 4 | MAD███.██ |
| United States | acquisition | 1 | 3 | USD███.██ |
| Bahrain | retail (max) | 2 | 2 | BHD███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
| Romania | max producer price | 2 | 2 | RON███.██ |
| United Arab Emirates | public | 1 | 1 | AED███.██ |
| Greece | producer price (ex-factory) | 1 | 1 | EUR███.██ |
124 pack listings across 105 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every Levonorgestrel And Estrogen pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Levonorgestrel And Estrogen in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Levonorgestrel And Estrogen, across 26 DINs, of which 18 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 5 | 5 | AVIANE 21, AVIANE 28, PORTIA 21, PORTIA 28, SEASONALE | Sourceable in Canada |
| APOTEX INC | 4 | 4 | ALYSENA 21, ALYSENA 28, OVIMA 21, OVIMA 28 | Sourceable in Canada |
| PFIZER CANADA ULC | 4 | 4 | ALESSE 21, ALESSE 28, MIN-OVRAL 21, MIN-OVRAL 28 | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | AUDRINA 21, AUDRINA 28 | Sourceable in Canada |
| LUPIN PHARMA CANADA LIMITED | 2 | 2 | LAYLAA 21, LAYLAA 28 | Sourceable in Canada |
| MYLAN PHARMACEUTICALS ULC | 3 | 1 | ESME 21, ESME 28, INDAYO | Sourceable in Canada |
| COBALT PHARMACEUTICALS COMPANY | 2 | 0 | LUTERA 21, LUTERA 28 | No marketed DIN |
| WYETH LTD. | 2 | 0 | MIN-OVRAL 21 TAB, MIN-OVRAL 28 TAB | No marketed DIN |
| GYNÉTICS LTD/LTÉE | 1 | 0 | PREVEN EMERGENCY CONTRACEPTIVE | No marketed DIN |
| SHIRE PHARMA CANADA ULC | 1 | 0 | PREVEN TABLETS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.03 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Levonorgestrel And Estrogen |
|---|---|
| ATC code | G03AA07 |
| AHFS class | 68:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02398869 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2398869 |
| Brand name | INDAYO |
| Generic / active ingredient | ETHINYL ESTRADIOL : 0.03 MG LEVONORGESTREL : 0.15 MG |
| Market authorization holder | MYLAN PHARMACEUTICALS ULC |
| Health Canada schedule | Prescription |
| ATC code | G03AA07 |
| ATC anatomical main group | G — Genito-urinary system and sex hormones |
| ATC therapeutic subgroup | G03AA |
| Current status | MARKETED |
| Status date | 08-Jul-2026 |
| Original market date | 2016-09-01 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
18 of 26 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALESSE 21 | 100 MCG | TABLET | PFIZER CANADA ULC | MARKETED | 02236974 |
| ALESSE 28 | 20 MCG | TABLET | PFIZER CANADA ULC | MARKETED | 02236975 |
| ALYSENA 21 | 20 MCG | TABLET | APOTEX INC | MARKETED | 02387875 |
| ALYSENA 28 | 20 MCG | TABLET | APOTEX INC | MARKETED | 02387883 |
| AUDRINA 21 | 100 MCG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02532174 |
| AUDRINA 28 | 100 MCG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02532182 |
| AVIANE 21 | 20 MCG | TABLET | TEVA CANADA LIMITED | MARKETED | 02298538 |
| AVIANE 28 | 100 MCG | TABLET | TEVA CANADA LIMITED | MARKETED | 02298546 |
| LAYLAA 21 | 100 MCG | TABLET | LUPIN PHARMA CANADA LIMITED | MARKETED | 02424282 |
| LAYLAA 28 | 20 MCG | TABLET | LUPIN PHARMA CANADA LIMITED | MARKETED | 02424290 |
2 · Same class — other molecules in ATC G03AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Levonorgestrel And Estrogen | ALESSE 21 · ALESSE 28 · ALYSENA 21 · ALYSENA 28 · +22 more | 26 | 18 | Yes |
| Drospirenone And Estrogen | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 21 · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS 28 · DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP · +16 more | 20 | 10 | Yes |
| Desogestrel And Estrogen | APRI 21 · APRI 28 · FREYA 21 · FREYA 28 · +12 more | 16 | 10 | Yes |
| Norethisterone And Estrogen | BREVICON 0.5/35 21 TAB · BREVICON 0.5/35 28 TAB · BREVICON 0.5/35 TABLETS (21-DAY PACK) · BREVICON 0.5/35 TABLETS (28-DAY PACK) · +19 more | 25 | 6 | Yes |
| Norelgestromin And Estrogen | EVRA · EVRA -(6/0.75) | 2 | 1 | Yes |
| Drospirenone And Estetrol | NEXTSTELLIS | 1 | 1 | Yes |
| Norgestimate And Estrogen | CYCLEN TABLETS (21 DAY) · CYCLEN TABLETS (28 DAY) · PREVIFEM (21DAY) · PREVIFEM (28DAY) · +2 more | 6 | 0 | Not in Canada |
| Norgestrel And Estrogen | LO-FEMENAL 21 TABLETS · OVRAL 21 · OVRAL 21 TAB · OVRAL 28 TABLETS · +1 more | 5 | 0 | Not in Canada |
| Etynodiol And Estrogen | DEMULEN 30 (21 DAY PACK) · DEMULEN 30 (28 DAY PACK) · DEMULEN 50 (21 DAY PACK) · DEMULEN 50 (28 DAY PACK) | 4 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC G03A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| G03AB | Desogestrel And Estrogen · Dienogest And Estrogen · Levonorgestrel And Estrogen · Norethisterone And Estrogen · Norgestimate And Estrogen · +2 more | 40 | 14 |
| G03AC | Drospirenone · Etonogestrel · Levonorgestrel · Medroxyprogesterone · Norethisterone · +1 more | 13 | 6 |
| G03AD | Levonorgestrel · Ulipristal | 14 | 5 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is INDAYO called?
Also recorded in Canada as: {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Zarah] (US), {28 (ethinyl estradiol 0.02 MG / levonorgestrel 0.09 MG Oral Tablet) } Pack [Amethyst 28 Day] (US), {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Junel 1/20 21 Day] (US), {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Loestrin 1/20 21 Day] (US), {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Microgestin 1/20 21 Day] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Junel 1.5/30 21 Day] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Loestrin 1.5/30 21 Day] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Microgestin 1.5/30 21 Day] (US), {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Larin 1/20] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Larin 1.5/30] (US), {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Aurovela 1/20 21 Day] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Aurovela 1.5/30 21 Day] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Hailey 1.5/30 21 Day] (US), {28 (ethinyl estradiol 0.02 MG / levonorgestrel 0.09 MG Oral Tablet) } Pack [Dolishale 28 Day] (US), {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Luizza 1.5/30 21 Day] (US).
The same molecule, Levonorgestrel And Estrogen, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Mirena | Latin | Australia, Brazil, Norway, South Africa |
| Kyleena | Latin | Australia, Brazil, Norway, South Africa |
| LEVONORGESTREL | Latin | Brazil |
| Leverette | Latin | Sweden |
| Levonorgestrel/Etinylestradiol Ebb | Latin | Sweden |
| Logynon ED | Latin | Australia, South Africa |
| Microgynon | Latin | Norway |
| Microval | Latin | Morocco, South Africa |
| NORLEVO | Latin | Morocco, South Africa |
| Prionelle | Latin | Sweden |
| Rigevidoncont | Latin | Sweden |
| Avibela | Latin | South Africa |
| DIAD | Latin | Brazil |
| Ekuvor | Latin | South Africa |
| Escapelle Tablet | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.